SG Americas Securities
CTSO icon

SG Americas Securities’s Cytosorbents Corp CTSO Stock Holding History

SG Americas Securities’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,044
Closed -$114K – 3456
2021
Q3 		$114K Buy
+14,044
New +$114K ﹤0.01% 3602
2020
Q3 		– Sell
-18,777
Closed -$186K – 2849
2020
Q2 		$186K Buy
18,777
+8,013
+74% +$73.6K ﹤0.01% 2917
2020
Q1 		$83K Buy
+10,764
New +$54.3K ﹤0.01% 3068

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SG Americas Securities's CTSO Position: Q4 2021 in Review

SG Americas Securities sold out of Cytosorbents Corp (CTSO) in Q4 2021, closing a stake of 14,044 shares — an estimated $114K sold.

SG Americas Securities first reported a position in CTSO in Q1 2020 and held it in 3 quarters. The position peaked at $186K in Q2 2020. 91 funds tracked by Wall St. Rank hold CTSO as of Q4 2021.

  • SG Americas Securities reported no remaining Cytosorbents Corp position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 14,044 Cytosorbents Corp shares in Q4 2021, an estimated $114K.
  • SG Americas Securities first reported a position in Cytosorbents Corp in Q1 2020 and held it in 3 quarters.
  • SG Americas Securities's Cytosorbents Corp position peaked at $186K in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.